• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非洲人群对 COVID-19 的保护:免疫学、遗传学和疟疾对治疗靶点的启示。

Protection against COVID-19 in African population: Immunology, genetics, and malaria clues for therapeutic targets.

机构信息

Private Practice of Neurology, Neuroceuta. (Virgen de África Clinic), Ceuta, Spain.

UNIR Research, Universidad Internacional de La Rioja, Madrid, Spain.

出版信息

Virus Res. 2021 Jul 2;299:198347. doi: 10.1016/j.virusres.2021.198347. Epub 2021 Feb 22.

DOI:10.1016/j.virusres.2021.198347
PMID:33631219
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7898966/
Abstract

BACKGROUND

There is a marked discrepancy between SARS-CoV-2 seroprevalence and COVID-19 cases and deaths in Africa. MAIN: SARS-CoV-2 stimulates humoral and cellular immunity systems, as well as mitogen-activated protein kinase (MAPK) and nuclear NF-kB signalling pathways, which regulate inflammatory gene expression and immune cell differentiation. The result is pro-inflammatory cytokines release, hyperinflammatory condition, and cytokine storm, which provoke severe lung alterations that can lead to multi-organ failure in COVID-19. Multiple genetic and immunologic factors may contribute to the severity of COVID-19 in African individuals when compared to the rest of the global population. In this article, the role of malaria, NF-kB and MAPK pathways, caspase-12 expression, high level of LAIR-1-containing antibodies, and differential glycophorins (GYPA/B) expression in COVID-19 are discussed.

CONCLUSION

Understanding pathophysiological mechanisms can help identify target points for drugs and vaccines development against COVID-19. To our knowledge, this is the first study that explores this link and proposes a biological and molecular answer to the epidemiologic discrepancy in COVID-19 in Africa.

摘要

背景

在非洲,SARS-CoV-2 的血清流行率与 COVID-19 病例和死亡之间存在显著差异。

主要内容

SARS-CoV-2 刺激体液和细胞免疫系统,以及丝裂原活化蛋白激酶(MAPK)和核 NF-kB 信号通路,调节炎症基因表达和免疫细胞分化。其结果是促炎细胞因子的释放、过度炎症状态和细胞因子风暴,导致 COVID-19 中严重的肺部改变,可能导致多器官衰竭。与全球其他人群相比,多种遗传和免疫因素可能导致非洲个体 COVID-19 的严重程度不同。本文讨论了疟疾、NF-kB 和 MAPK 通路、半胱天冬酶-12 表达、高含量含 LAIR-1 抗体以及不同糖蛋白(GYPA/B)表达在 COVID-19 中的作用。

结论

了解病理生理机制有助于确定针对 COVID-19 的药物和疫苗开发的靶点。据我们所知,这是第一项探讨这一联系的研究,并为非洲 COVID-19 流行病学差异提出了生物学和分子答案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a61/7898966/dece9d6c9ffe/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a61/7898966/5eae0faab308/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a61/7898966/dece9d6c9ffe/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a61/7898966/5eae0faab308/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a61/7898966/dece9d6c9ffe/gr2_lrg.jpg

相似文献

1
Protection against COVID-19 in African population: Immunology, genetics, and malaria clues for therapeutic targets.非洲人群对 COVID-19 的保护:免疫学、遗传学和疟疾对治疗靶点的启示。
Virus Res. 2021 Jul 2;299:198347. doi: 10.1016/j.virusres.2021.198347. Epub 2021 Feb 22.
2
Caspase-12 dampens the immune response to malaria independently of the inflammasome by targeting NF-kappaB signaling.Caspase-12 通过靶向 NF-κB 信号通路,独立于炎症小体抑制疟原虫感染诱导的免疫反应。
J Immunol. 2010 Nov 1;185(9):5495-502. doi: 10.4049/jimmunol.1002517. Epub 2010 Sep 27.
3
COVID-19: Mechanistic Model of the African Paradox Supports the Central Role of the NF-κB Pathway.COVID-19:非洲悖论的机械模型支持 NF-κB 通路的核心作用。
Viruses. 2021 Sep 21;13(9):1887. doi: 10.3390/v13091887.
4
SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity.SARS-CoV-2 N 蛋白靶向 TRIM25 介导的 RIG-I 激活以抑制先天免疫。
Viruses. 2021 Jul 23;13(8):1439. doi: 10.3390/v13081439.
5
Malaria and the incidence of COVID-19 in Africa: an ecological study.疟疾与非洲 COVID-19 发病率:一项生态学研究。
BMC Infect Dis. 2023 Feb 3;23(1):66. doi: 10.1186/s12879-023-08032-2.
6
Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.新型冠状病毒-19(SARS-CoV-2)通过白细胞介素-1(IL-1)引起细胞因子风暴导致 COVID-19 的急性重症肺部炎症:一种有前途的抑制策略。
J Biol Regul Homeost Agents. 2020 Nov-Dec;34(6):1971-1975. doi: 10.23812/20-1-E.
7
SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms.SARS-CoV-2 病毒蛋白 NSP1 和 NSP13 通过不同机制抑制干扰素的激活。
PLoS One. 2021 Jun 24;16(6):e0253089. doi: 10.1371/journal.pone.0253089. eCollection 2021.
8
Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone.新型冠状病毒刺突糖蛋白 S1 重组蛋白诱导人外周血单个核细胞过度细胞因子产生及其地塞米松抑制作用。
Inflammation. 2021 Oct;44(5):1865-1877. doi: 10.1007/s10753-021-01464-5. Epub 2021 Apr 16.
9
Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin.辛伐他汀可阻断 SARS-CoV-2 核衣壳蛋白对血管内皮细胞的直接激活。
J Virol. 2021 Nov 9;95(23):e0139621. doi: 10.1128/JVI.01396-21. Epub 2021 Sep 22.
10
Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.环孢素 A 通过三种 SARS-CoV-2 变体抑制肺细胞中的病毒感染和释放以及细胞因子产生。
Microbiol Spectr. 2022 Feb 23;10(1):e0150421. doi: 10.1128/spectrum.01504-21. Epub 2022 Jan 5.

引用本文的文献

1
Statins: Beneficial Effects in Treatment of COVID-19.他汀类药物:在治疗 COVID-19 中的有益作用。
Adv Exp Med Biol. 2023;1412:457-476. doi: 10.1007/978-3-031-28012-2_25.
2
SARS-CoV-2 at the Human-Animal Interface: Implication for Global Public Health from an African Perspective.SARS-CoV-2 在人类-动物界面:从非洲角度看对全球公共卫生的影响。
Viruses. 2022 Nov 9;14(11):2473. doi: 10.3390/v14112473.
3
African Genetic Representation in the Context of SARS-CoV-2 Infection and COVID-19 Severity.在SARS-CoV-2感染和新冠肺炎严重程度背景下的非洲遗传特征

本文引用的文献

1
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors.肯尼亚献血者中抗 SARS-CoV-2 IgG 抗体的血清流行率。
Science. 2021 Jan 1;371(6524):79-82. doi: 10.1126/science.abe1916. Epub 2020 Nov 11.
2
Mechanistic insights into SARS-CoV-2 epidemic via revealing the features of SARS-CoV-2 coding proteins and host responses upon its infection.通过揭示 SARS-CoV-2 编码蛋白的特征及其感染宿主后的反应,深入了解 SARS-CoV-2 疫情的发病机制。
Bioinformatics. 2021 Jan 29;36(21):5133-5138. doi: 10.1093/bioinformatics/btaa725.
3
Characteristics of peripheral blood differential counts in hospitalized patients with COVID-19.
Front Genet. 2022 May 10;13:909117. doi: 10.3389/fgene.2022.909117. eCollection 2022.
住院 COVID-19 患者外周血差异计数的特征。
Eur J Haematol. 2020 Dec;105(6):773-778. doi: 10.1111/ejh.13509. Epub 2020 Sep 20.
4
SARS-CoV-2 and the next generations: which impact on reproductive tissues?SARS-CoV-2 及其后代:对生殖组织有何影响?
J Assist Reprod Genet. 2020 Oct;37(10):2399-2403. doi: 10.1007/s10815-020-01917-0. Epub 2020 Aug 11.
5
NK cells: A double edge sword against SARS-CoV-2.自然杀伤细胞:对抗新冠病毒的双刃剑。
Adv Biol Regul. 2020 Aug;77:100737. doi: 10.1016/j.jbior.2020.100737. Epub 2020 Jun 13.
6
COVID-19 and immunological regulations - from basic and translational aspects to clinical implications.COVID-19 与免疫调控:基础与转化医学到临床应用
J Dtsch Dermatol Ges. 2020 Aug;18(8):795-807. doi: 10.1111/ddg.14169. Epub 2020 Aug 6.
7
Immunoregulatory complement receptor-1 and leukocyte-associated Ig-like receptor-1 expression on leukocytes in .白细胞表面免疫调节补体受体 1 和白细胞相关免疫球蛋白样受体 1 的表达。
Innate Immun. 2020 Nov;26(8):683-692. doi: 10.1177/1753425920942570. Epub 2020 Jul 30.
8
Inflammation: A bridge between diabetes and COVID-19, and possible management with sitagliptin.炎症:糖尿病与 COVID-19 之间的桥梁,西他列汀可能对此有一定的治疗作用。
Med Hypotheses. 2020 Oct;143:110111. doi: 10.1016/j.mehy.2020.110111. Epub 2020 Jul 15.
9
Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.在 COVID-19 中,单核细胞和巨噬细胞对局部组织炎症和细胞因子风暴的贡献:来自 SARS 和 MERS 的教训,以及潜在的治疗干预措施。
Life Sci. 2020 Sep 15;257:118102. doi: 10.1016/j.lfs.2020.118102. Epub 2020 Jul 18.
10
Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications.SARS-CoV-2 感染的免疫病理学:免疫细胞和介质、预后因素以及免疫治疗意义。
Int J Mol Sci. 2020 Jul 6;21(13):4782. doi: 10.3390/ijms21134782.